Total Payments
$879.22
2019 Payments
$86.56
Companies
12
Transactions
42
Medicare Patients
1,220
Medicare Billing
$149,698
Payment Breakdown by Category
Food & Beverage$879.22 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $879.22 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $189.50 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $105.28 | 8 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $105.16 | 8 | $0 (2018) |
| Allergan Inc. | $103.79 | 6 | $0 (2017) |
| Theravance Biopharma, Inc. | $92.28 | 5 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $86.56 | 1 | $0 (2019) |
| UCB, Inc. | $52.89 | 4 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $45.41 | 3 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $44.04 | 2 | $0 (2017) |
| Melinta Therapeutics, Inc. | $20.16 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $86.56 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($86.56) |
| 2018 | $163.68 | 6 | Novartis Pharmaceuticals Corporation ($81.18) |
| 2017 | $628.98 | 35 | Novartis Pharmaceuticals Corporation ($108.32) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $86.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/25/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $81.18 | General |
| 06/27/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/27/2018 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/07/2018 | Theravance Biopharma, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Infectious Disease | ||||||
| 01/10/2018 | Theravance Biopharma, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Infectious Disease | ||||||
| 12/12/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Neurology | ||||||
| 12/11/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $62.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/04/2017 | The Medicines Company | VABOMERE (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/21/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Infectious Disease | ||||||
| 11/13/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/12/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Neurology | ||||||
| 10/10/2017 | BOSTON SCIENTIFIC CORPORATION | VIGILANT (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: BRADY | ||||||
| 09/21/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Infectious Disease | ||||||
| 08/23/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/14/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/14/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Neurology | ||||||
| 07/20/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/17/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Infectious Disease | ||||||
| 07/14/2017 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Neurology | ||||||
| 07/12/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 141 | 201 | $42,470 | $15,555 |
| 2022 | 6 | 348 | 556 | $107,024 | $40,573 |
| 2021 | 6 | 445 | 651 | $142,998 | $56,058 |
| 2020 | 5 | 286 | 433 | $108,524 | $37,512 |
Total Patients
1,220
Total Services
1,841
Medicare Billing
$149,698
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 87 | $12,354 | $5,203 | 42.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 37 | $14,874 | $4,387 | 29.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 45 | $9,270 | $3,747 | 40.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 21 | $4,410 | $1,661 | 37.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $1,562 | $556.56 | 35.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 102 | 183 | $37,698 | $14,212 | 37.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 112 | 230 | $32,660 | $12,569 | 38.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 68 | 70 | $14,700 | $5,592 | 38.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $11,256 | $4,019 | 35.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $9,150 | $3,581 | 39.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 20 | $1,560 | $600.23 | 38.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 121 | 240 | $49,440 | $19,465 | 39.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 111 | 195 | $27,690 | $10,923 | 39.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 62 | 62 | $24,924 | $9,722 | 39.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 88 | 90 | $18,900 | $7,400 | 39.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 48 | 49 | $17,934 | $7,135 | 39.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $4,110 | $1,413 | 34.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 97 | 175 | $44,224 | $14,597 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 71 | 139 | $21,652 | $8,070 | 37.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 40 | 41 | $19,314 | $6,080 | 31.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 55 | 55 | $14,259 | $4,753 | 33.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 23 | 23 | $9,075 | $4,013 | 44.2% |
About Dr. Afrina Mujib, M.D
Dr. Afrina Mujib, M.D is a Internal Medicine healthcare provider based in Stoughton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891948592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Afrina Mujib, M.D has received a total of $879.22 in payments from pharmaceutical and medical device companies, with $86.56 received in 2019. These payments were reported across 42 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($879.22).
As a Medicare-enrolled provider, Mujib has provided services to 1,220 Medicare beneficiaries, totaling 1,841 services with total Medicare billing of $149,698. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Stoughton, MA
- Active Since 10/28/2008
- Last Updated 04/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891948592
Products in Payments
- ENTRESTO (Drug) $108.32
- XARELTO (Drug) $105.16
- VIBATIV (Drug) $92.28
- LifeVest (Device) $86.56
- DALVANCE (Drug) $62.42
- DIFICID (Drug) $47.19
- XIFAXAN (Drug) $45.41
- ZERBAXA (Drug) $42.95
- Briviact (Drug) $40.56
- TEFLARO (Drug) $32.37
- WATCHMAN DEVICE (Device) $27.52
- Orbactiv (Drug) $20.16
- VABOMERE (Drug) $17.36
- ELIQUIS (Drug) $16.79
- VIGILANT (Device) $16.52
- PNEUMOVAX 23 (Biological) $15.14
- Vimpat (Drug) $12.33
- AVYCAZ (Drug) $9.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Stoughton
Lawrence Hotes, M.d, M.D
Internal Medicine — Payments: $5,054
Internal Medicine $5,054
Mrs. Inas Almasry, Md, MD
Internal Medicine — Payments: $850.30
Internal Medicine $850.30
Brian Bloom, Md, MD
Internal Medicine — Payments: $264.23
Internal Medicine $264.23
Tzipora Wolff, Md, MD
Internal Medicine
Internal Medicine
Frederick Ng, Md, MD
Internal Medicine
Internal Medicine
Guirish Agni, Md, MD
Internal Medicine
Internal Medicine